Skip to search formSkip to main contentSkip to account menu

Stadol

Known as: Bristol-Myers Squibb Brand of Butorphanol Tartrate, Stadol NS, Cephalon Brand of Butorphanol Tartrate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Background:Reliable data on HIV infection among Russian street youth are unavailable. The purpose of this study was to assess HIV… 
2000
2000
PURPOSE This study evaluated the safety and efficacy of increasing doses of intranasal butorphanol (Stadol NS, Bristol-Myers… 
Highly Cited
1997
Highly Cited
1997
Butorphanol (Stadol, Bristol-Meyers Squibb, Princeton, NJ) is a synthetically derived opiate. As a nasal spray, it was approved… 
Highly Cited
1995
Highly Cited
1995
Several studies on propofol (Diprivan) for induction of anaesthesia during caesarean section have demonstrated its safety… 
Review
1991
Review
1991
Butorphanol tartrate (Stadol; Anaquest, Madison, WI/Bristol-Meyers Squibb, Evansville, IN) is an analgesic possessing mixed… 
1985
1985
To the Editor.— In their April 19, 1985, letter to the editor, Dr Evans et al 1 report a case of physical dependence on Stadol… 
1985
1985
1985
1985
To the Editor.— Stadol (butorphanol tartrate) was introduced in 1978 as a potent synthetic opiate agonist-antagonist indicated… 
1979
1979
: Butorphanol, levo-N-cyclobutylmethyl-3,14 beta-dihydroxy-morphinan, is a new agonist-antagonist type analgetic agent which is 4…